BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31364053)

  • 1. Isolation of Major Histocompatibility Complex (MHC)-Associated Peptides by Immunoaffinity Purification.
    Penny SA; Malaker SA
    Methods Mol Biol; 2019; 2024():235-243. PubMed ID: 31364053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of a Predictive Cleavage Motif for Eluted Major Histocompatibility Complex Class II Ligands.
    Paul S; Karosiene E; Dhanda SK; Jurtz V; Edwards L; Nielsen M; Sette A; Peters B
    Front Immunol; 2018; 9():1795. PubMed ID: 30127785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular basis for detection of infectious agents].
    Siegrist CA
    Schweiz Med Wochenschr; 1996 Feb; 126(7):246-54. PubMed ID: 8720322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of MHC ligands in clinical material by immunoaffinity-mass spectrometry.
    Kasuga K
    Methods Mol Biol; 2013; 1023():203-18. PubMed ID: 23765629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presentation of a self-peptide for in vivo tolerance induction of CD4+ T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus.
    Fedoseyeva EV; Tam RC; Orr PL; Garovoy MR; Benichou G
    J Exp Med; 1995 Nov; 182(5):1481-91. PubMed ID: 7595218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8 T cells, like CD4 T cells, are triggered by multivalent engagement of TCRs by MHC-peptide ligands but not by monovalent engagement.
    Stone JD; Stern LJ
    J Immunol; 2006 Feb; 176(3):1498-505. PubMed ID: 16424178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [MHC tetramers: tracking specific immunity].
    Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
    Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis.
    Sirois I; Isabelle M; Duquette JD; Saab F; Caron E
    J Vis Exp; 2021 Oct; (176):. PubMed ID: 34723952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and Identification of Naturally Presented MHC Class I and II Ligands.
    Nelde A; Kowalewski DJ; Stevanović S
    Methods Mol Biol; 2019; 1988():123-136. PubMed ID: 31147937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous presentation of a nascent antigenic epitope to CD8+ CTL is more efficient than exogenous presentation.
    Hahn YS; Hahn CS; Braciale TJ
    Immunol Cell Biol; 1996 Oct; 74(5):394-400. PubMed ID: 8912001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mild Acid Elution and MHC Immunoaffinity Chromatography Reveal Similar Albeit Not Identical Profiles of the HLA Class I Immunopeptidome.
    Sturm T; Sautter B; Wörner TP; Stevanović S; Rammensee HG; Planz O; Heck AJR; Aebersold R
    J Proteome Res; 2021 Jan; 20(1):289-304. PubMed ID: 33141586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Composition of the HLA-DR-associated human thymus peptidome.
    Collado JA; Alvarez I; Ciudad MT; Espinosa G; Canals F; Pujol-Borrell R; Carrascal M; Abian J; Jaraquemada D
    Eur J Immunol; 2013 Sep; 43(9):2273-82. PubMed ID: 23719902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival and homeostatic proliferation of naive peripheral CD4+ T cells in the absence of self peptide:MHC complexes.
    Clarke SR; Rudensky AY
    J Immunol; 2000 Sep; 165(5):2458-64. PubMed ID: 10946271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carrier-independent hapten recognition and promiscuous MHC restriction by CD4 T cells induced by trinitrophenylated peptides.
    Kohler J; Hartmann U; Grimm R; Pflugfelder U; Weltzien HU
    J Immunol; 1997 Jan; 158(2):591-7. PubMed ID: 8992972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major histocompatibility class II molecules prevent destructive processing of exogenous peptides at the cell surface of macrophages for presentation to CD4 T cells.
    von Delwig A; Musson JA; Gray J; McKie N; Robinson JH
    Immunology; 2005 Feb; 114(2):194-203. PubMed ID: 15667564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and Screening of an Antigen-Derived Peptide Library Displayed on Yeast Cell Surface for CD4+ T Cell Epitope Identification.
    Wen F; Smith MR; Zhao H
    Methods Mol Biol; 2019; 2024():213-234. PubMed ID: 31364052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noble metals strip peptides from class II MHC proteins.
    De Wall SL; Painter C; Stone JD; Bandaranayake R; Wiley DC; Mitchison TJ; Stern LJ; DeDecker BS
    Nat Chem Biol; 2006 Apr; 2(4):197-201. PubMed ID: 16505807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptides corresponding to CD4-interacting regions of murine MHC class II molecules modulate immune responses of CD4+ T lymphocytes in vitro and in vivo.
    Shen X; Hu B; McPhie P; Wu X; Fox A; Germain RN; König R
    J Immunol; 1996 Jul; 157(1):87-100. PubMed ID: 8683160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
    Lustgarten J; Waks T; Eshhar Z
    Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of MHC-Bound Peptides from Dendritic Cells Infected with Salmonella enterica Strain SL1344: Implications for a Nontyphoidal Salmonella Vaccine.
    Karunakaran KP; Yu H; Jiang X; Chan Q; Goldberg MF; Jenkins MK; Foster LJ; Brunham RC
    J Proteome Res; 2017 Jan; 16(1):298-306. PubMed ID: 27802388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.